|

Platinum Compound Clinical Trials

2 actively recruiting trials across 2 locations

No change since May 2026

Also known as: Platinum Agents, Platinum-Based Chemotherapeutic Agent

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • SWOG Cancer Research Network1
  • National Cancer Institute (NCI)1

Indications

  • Cancer2
  • Systemic Scleroderma1
  • Systemic Lupus Erythematosus1
  • Sjogren Syndrome1
  • Psoriatic Arthritis1

Birmingham, Alabama1 trial

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

University of Alabama at Birmingham Cancer Center

Phase 1

Loma Linda, California1 trial

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

Loma Linda University Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.